XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

AIMS: Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, there is a need for safety and efficacy data from unselected patients in everyday clinical practice. XANTUS inve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Hess, Susanne, Kirchhof, Paulus, Kuhls, Silvia, van Eickels, Martin, Turpie, Alexander G.G.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
FASTTRACK ESC Clinical Registry
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4823634/
https://ncbi.nlm.nih.gov/pubmed/26330425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv466
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars